Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-05-22Clinical Trial Update: Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients
The document provides an update on a clinical trial evaluating changes in fatigue and physical fitness in hospitalized hematology patients w…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the combination of liposomal doxorubicin (Doxil) and bortezomib in patients with refractory hematol…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Cellular Therapy With Cord Blood Cells [Phase 2]
Phase 2 trial evaluating cord blood cell–based cellular therapy in patients with multiple myeloma, leukemia, or lymphoma. Results were poste…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas [Phase 1]
A Phase 1 safety study of SNX-5422 for solid tumor malignancies and lymphoid cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Chemotherapy in Treating Patients Who Have Hematologic Cancer [Phase 1]
A Phase 1 chemotherapy trial sponsored by Daiichi Sankyo for leukemia and myelodysplastic syndromes has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating paclitaxel in patients with refractory or recurrent acute leukemia or chronic myelogenous leukemia has…
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Palifermin After Haploidentical PBSCT [Phase 2]
A Phase 2 trial evaluating palifermin after haploidentical peripheral blood stem cell transplantation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating umbilical cord blood-derived mesenchymal stem cells to promote engraftment in unrelated hemato…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 trial of azacitidine, darbepoetin alfa, erythropoietin, and G-CSF in myelodysplastic syndromes; study terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study [EARLY_Phase 1]
Completed EARLY Phase 1 pilot trial evaluating the effects of health counseling and exercise in patients with acute leukemia.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J
Clinical trial update on the use of arsenic trioxide in young patients with leukemia or lymphoma treated on NCI-00-C-0070J.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating umbilical cord blood transplantation for high-risk hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Tipifarnib in Treating Young Patients With Refractory Leukemia [Phase 1]
A Phase 1 trial assessing Tipifarnib in young patients with refractory leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer [Phase 1]
Phase 1 study of ABT-888 (veliparib) in patients with refractory solid tumors or hematologic cancers conducted by NIH Clinical Center; the t…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy [Phase 1]
Phase 1 pediatric trial update reports initial safety and dosing information for ixabepilone in children with relapsed or refractory solid t…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
This completed clinical trial evaluated caregiver support and its effect on the quality of life of patients receiving donor bone marrow tran…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Children's Resiliency, Adjustment, and Coping
The document reports the completion of a clinical trial investigating resiliency, adjustment, and coping in children with leukemia.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Blood Samples to Evaluate Biomarkers of Donor Chimerism
The document summarizes a completed trial examining blood-based biomarkers of donor chimerism. The study involves patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) [Phase 2]
Phase 2 clinical trial update for Ontak (denileukin diftitox) in patients with systemic mastocytosis and leukemia. The study status is compl…
-
CLINICAL_TRIALS withdrawal · 2012-01-23Clinical Trial Update: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens [Phase 2]
A Phase 2 study of forodesine hydrochloride in relapsed/refractory precursor T-lymphoblastic leukemia/lymphoma was terminated; no efficacy r…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS [Phase 2]
This Phase 2 trial studied selective T-cell depletion in stem cell transplantation to reduce graft-versus-host disease. It included patients…
-
CLINICAL_TRIALS research · 2012-01-13Clinical Trial Update: HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating HLA-haploidentical hematopoietic stem cell transplantation in children and adolescents with acute …
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies [Phase 1]
This update covers a Phase 1 trial of anti-third-party donor T lymphocytes with nonmyeloablative stem cell transplantation for indolent lymp…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Non-Ablative Allo HSCT For Hematologic Malignancies or SAA [Phase 2]
Phase 2 trial update evaluating non-ablative allogeneic hematopoietic stem cell transplantation for hematologic malignancies and severe apla…